본문으로 건너뛰기
cccskills
무료GitHub에 공개

pdm-glp1ra-discontinuation-timing

Recommends discontinuation of GLP-1RA before conception rather than between start of pregnancy and end of first trimester for individuals with type 2 diabetes who are planning pregnancy. Trigger when clinician considers stopping GLP-1RA therapy in a patient with type 2 diabetes who is planning pregnancy or seeking preconception care.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL

실행 점수 미검증

설치 방법 보기

포함된 파일(1)

  • SKILL.md2.5 KB

SKILL.md(원문)

설치하기 전에 에이전트에게 전달되는 지시 내용을 확인할 수 있습니다.

Discontinue GLP-1RA before conception in type 2 diabetes

STEP 1 — Gather Information

Collect pregnancy intention, current GLP-1RA regimen and dosing, contraception method, HbA1c, weight, renal function, and anticipated timing of conception after contraception cessation.

STEP 2 — Rule In / Rule Out

Rule in: patient with type 2 diabetes mellitus currently on a GLP-1RA who is planning pregnancy or seeking preconception care; rule out: patient not planning pregnancy, already pregnant, has type 1 diabetes, or is not on a GLP-1RA.

STEP 3 — Classify or Stratify

Stratify by anticipated conception timing (<1 month, 1–3 months, >3 months) and GLP-1RA half‑life (short‑acting e.g., lixisenatide vs long‑acting e.g., semaglutide) to determine discontinuation window and need for insulin transition.

STEP 4 — Decide

Discontinue GLP-1RA at least 1 month before desired conception for short‑acting agents and 2 months for long‑acting agents; initiate insulin or other pregnancy‑safe antihyperglycemic agent; maintain effective contraception until conception is desired; optimize glycemia to HbA1c <6.5% before conception attempt.

Clinical Guardrails / Mimics / Pitfalls

Do not discontinue GLP-1RA without ensuring effective contraception to avoid hyperglycemia‑related teratogenicity; avoid abrupt cessation leading to weight gain and hyperglycemia; do not delay discontinuation until after pregnancy confirmation; do not neglect active glycemic management after GLP-1RA stop; do not overlook risks of prolonged time off GLP-1RA such as rebound weight gain.

Concrete Clinical Example

A 32‑year‑old woman with type 2 diabetes on semaglutide 1 mg weekly desires pregnancy in the next 3 months and uses condoms. Advise to stop semaglutide now, start basal‑bolus insulin titrated to fasting <95 mg/dL, continue contraception for another month to allow washout, then attempt conception after confirming HbA1c <6.5% and stable weight.

Source: Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline, Endocrine Society, 2025, https://doi.org/10.1210/clinem/dgaf288

리뷰

아직 리뷰가 없습니다. 사용해 본 소감을 남겨 주세요.

댓글

로그인 없이 쓸 수 있습니다. 사용 후기, 질문, 작동하지 않은 환경 등을 편하게 남겨 주세요.

아직 댓글이 없습니다. 첫 댓글을 남겨 보세요.

보내면 바로 공개됩니다. 이메일 주소나 전화번호 같은 개인 정보는 쓰지 마세요. URL은 2개까지입니다.

0 / 1,000자

이 양식은 reCAPTCHA로 보호되며 Google 개인정보처리방침 및 서비스 약관이 적용됩니다.

같은 저장소의 스킬

780g-pump-adjustment

무료

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

ata-acth-stim-test-interpretation

무료

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

ata-adrenal-crisis-treatment

무료

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

ata-aed-ai-education

무료

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

ata-aed-lt4-monitoring

무료

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

ata-cortisol-cutoff-ai-diagnosis

무료

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

dromlakhani의 스킬 모두 보기

이 스킬의 문제 신고